Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe Publications section now clarifies that items are automatically filled from PubMed and may not be about the study, and the revision label updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedA government funding status notice has been removed from the page; this is a minor, non-impactful change that does not affect trial data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check32 days agoChange DetectedThe page previously showing 'No Results Posted' now shows 'Results Submitted', indicating that trial results have been submitted to ClinicalTrials.gov. This informs users about the current availability status of the study's results.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check68 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update aSummaryDifference0.1%

- Check82 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element; no core content, pricing, stock, or time-related information changed.SummaryDifference0.1%

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.